✦ LIBER ✦

Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis

✍ Scribed by M. Bonomi; R. Nortilli; A. Molino; T. Sava; A. Santo; A. Caldara; G. L. Cetto

Book ID: 107576826
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 207 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9195-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal safety and osteonecrosis of the ja

Renal safety and osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates

✍ Sercan Aksoy; Omer Dizdar; Kadri Altundag 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 97 KB

A case of osteonecrosis of the jaw in a

A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates

✍ Yukako Mouri; Miwa Yoshida; Shogo Nakano; Kyoko Yorozuya; Kimihito Fujii; Takash 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 175 KB

Osteonecrosis of the jaw (ONJ) in cancer

Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution

✍ Nicla La Verde; Claudia Bareggi; Marina Garassino; Karen Borgonovo; Paola Sburla 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 102 KB

Long-term follow-up and a detailed progn

Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy

✍ Natsuo Tomita; Takeshi Kodaira; Kazuhisa Furutani; Hiroyuki Tachibana; Yasuhisa 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 319 KB

The role of S-adenosylmethionine in prev

The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen

✍ Bruno Vincenzi; Santini Daniele; Anna Maria Frezza; Pierpaolo Berti; Umberto Ves 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 100 KB

Adherence and profile of non-persistence

Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

✍ J. C. Netelenbos; P. P. Geusens; G. Ypma; S. J. E. Buijs 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 190 KB

## Summary We analyzed 12-month compliance for all ten oral osteoporosis drugs in the Netherlands by medication possession ratio (MPR ≥ 80%) in 105,506 patients, and persistence in 8,626 starters indicated high MPR (91%), low persistence (43%), and no restart in 78% of the stoppers after 18 months.